MEN1 and acute leukemia: Menin inhibitors have shown promising therapeutic potential in preclinical models of multiple cancer types (Table 4) and are currently being investigated in clinical trials for acute leukemias and some solid tumor types (Table 1, Table 2 and Table 3).